Found: 25
Select item for more details and to access through your institution.
Advancing therapy with iGlarLixi versus premix BIAsp 30 in basal insulin‐treated type 2 diabetes: Design and baseline characteristics of the SoliMix randomized controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 6, p. 1221, doi. 10.1111/dom.14354
- By:
- Publication type:
- Article
Gastrointestinal adverse events with insulin glargine/lixisenatide fixed‐ratio combination versus glucagon‐like peptide‐1 receptor agonists in people with type 2 diabetes mellitus: A network meta‐analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 1, p. 136, doi. 10.1111/dom.14202
- By:
- Publication type:
- Article
Effectiveness of premixed insulin to achieve glycaemic control in type 2 diabetes: A retrospective UK cohort study.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 4, p. 929, doi. 10.1111/dom.14298
- By:
- Publication type:
- Article
Insulin glargine/lixisenatide fixed-ratio combination (iGlarLixi) compared with premix or addition of meal-time insulin to basal insulin in people with type 2 diabetes: A systematic review and Bayesian network meta-analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 11, p. 2179, doi. 10.1111/dom.14148
- By:
- Publication type:
- Article
Efficacy and safety of iGlarLixi versus IDegLira in adults with type 2 diabetes inadequately controlled by glucagon-like peptide-1 receptor agonists: a systematic literature review and indirect treatment comparison.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 11, p. 2170, doi. 10.1111/dom.14136
- By:
- Publication type:
- Article
Achievement of glycaemic control is associated with improvements in lipid profile with iGlarLixi versus iGlar: A post hoc analysis of the LixiLan‐L trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 12, p. 2712, doi. 10.1111/dom.13857
- By:
- Publication type:
- Article
Cover Image, Volume 21, Issue 12.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 12, p. i, doi. 10.1111/dom.13903
- By:
- Publication type:
- Article
Achievement of glycaemic control is associated with improvements in lipid profile with iGlarLixi versus iGlar: A post hoc analysis of the LixiLan‐L trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 12, p. 2712, doi. 10.1111/dom.13857
- By:
- Publication type:
- Article
ApoA-I Infusion Therapies Following Acute Coronary Syndrome: Past, Present, and Future.
- Published in:
- Current Atherosclerosis Reports, 2022, v. 24, n. 7, p. 585, doi. 10.1007/s11883-022-01025-7
- By:
- Publication type:
- Article
Correlation of telomere length and telomerase activity with occult ovarian insufficiency.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Response to letter to the editor regarding "Development and validation of a predictive model algorithm to identify anaphylaxis in adults with type 2 diabetes in U.S. administrative claims data".
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 1, p. 110, doi. 10.1002/pds.5376
- By:
- Publication type:
- Article
Development and validation of a predictive model algorithm to identify anaphylaxis in adults with type 2 diabetes in U.S. administrative claims data.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 7, p. 918, doi. 10.1002/pds.5257
- By:
- Publication type:
- Article
Evaluating glycaemic control in patients poorly controlled on oral antidiabetic drugs in real‐world setting: Results from assessing the Appropriate Timing of Type 2 diAbetes INtensification (ATTAIN).
- Published in:
- Endocrinology, Diabetes & Metabolism, 2020, v. 3, n. 1, p. N.PAG, doi. 10.1002/edm2.94
- By:
- Publication type:
- Article
Clinical implications of prolonged hyperglycaemia before basal insulin initiation in type 2 diabetes patients: An electronic medical record database analysis.
- Published in:
- Endocrinology, Diabetes & Metabolism, 2019, v. 2, n. 3, p. N.PAG, doi. 10.1002/edm2.61
- By:
- Publication type:
- Article
Baseline dimensions of the human vagina.
- Published in:
- Human Reproduction, 2006, v. 21, n. 6, p. 1618, doi. 10.1093/humrep/del022
- By:
- Publication type:
- Article
Understanding Reasons for Treatment Discontinuation, Attitudes and Education Needs Among People Who Discontinue Type 2 Diabetes Treatment: Results from an Online Patient Survey in the USA and UK.
- Published in:
- Diabetes Therapy, 2020, v. 11, n. 8, p. 1873, doi. 10.1007/s13300-020-00843-9
- By:
- Publication type:
- Article
Evaluating Glycemic Control in Patients with Type 2 Diabetes Suboptimally Controlled on Basal Insulin: UK ATTAIN Real-World Study.
- Published in:
- Diabetes Therapy, 2019, v. 10, n. 5, p. 1847, doi. 10.1007/s13300-019-0667-6
- By:
- Publication type:
- Article
Probability of Achieving Glycemic Control with Basal Insulin in Patients with Type 2 Diabetes in Real-World Practice in the USA.
- Published in:
- Diabetes Therapy, 2018, v. 9, n. 3, p. 1347, doi. 10.1007/s13300-018-0413-5
- By:
- Publication type:
- Article
Glucagon-like Peptide-1 Receptor Agonist Treatment Attributes Important to Injection-Naïve Patients with Type 2 Diabetes Mellitus: A Multinational Preference Study.
- Published in:
- Diabetes Therapy, 2017, v. 8, n. 2, p. 321, doi. 10.1007/s13300-017-0230-2
- By:
- Publication type:
- Article
Glucagon-Like Peptide-1 Receptor Agonist Treatment Attributes Important to Injection-Experienced Patients with Type 2 Diabetes Mellitus: A Preference Study in Germany and the United Kingdom.
- Published in:
- Diabetes Therapy, 2017, v. 8, n. 2, p. 335, doi. 10.1007/s13300-017-0237-8
- By:
- Publication type:
- Article
A Network Meta-analysis Comparing Exenatide Once Weekly with Other GLP-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus.
- Published in:
- Diabetes Therapy, 2016, v. 7, n. 1, p. 27, doi. 10.1007/s13300-016-0155-1
- By:
- Publication type:
- Article
959-P: Indirect Treatment Comparison (ITC) of IGlarLixi vs. IDegLira in Adults Inadequately Controlled by GLP-1 Receptor Agonists (GLP-1RAs).
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-959-P
- By:
- Publication type:
- Article
2232-PUB: Reasons for Treatment Discontinuation in Type 2 Diabetes (T2D): Results from an Online Patient Survey in the UK and U.S.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-2232-PUB
- By:
- Publication type:
- Article
1029-P: Effectiveness of Premix Insulin (Premix) in Type 2 Diabetes (T2D): A Retrospective UK Cohort Study.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1029-P
- By:
- Publication type:
- Article
1132-P: Real-World Clinical Use of iGlarLixi in a Large U.S. Electronic Medical Records Database.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1132-P
- By:
- Publication type:
- Article